A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 762,900 shares of DARE stock, worth $312,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares
762,900
Previous 719,400 6.05%
Holding current value
$312,789
Previous $222,000 68.47%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.31 - $0.57 $13,485 - $24,794
43,500 Added 6.05%
762,900 $374,000
Q4 2023

Feb 13, 2024

BUY
$0.29 - $0.53 $14,093 - $25,758
48,600 Added 7.25%
719,400 $222,000
Q3 2023

Nov 14, 2023

SELL
$0.46 - $0.91 $22,089 - $43,699
-48,021 Reduced 6.68%
670,800 $310,000
Q2 2023

Aug 11, 2023

BUY
$0.91 - $1.05 $136,283 - $157,250
149,762 Added 26.32%
718,821 $654,000
Q1 2023

May 12, 2023

BUY
$0.87 - $1.36 $59,478 - $92,977
68,366 Added 13.65%
569,059 $592,000
Q4 2022

Feb 13, 2023

SELL
$0.82 - $1.03 $122,431 - $153,786
-149,307 Reduced 22.97%
500,693 $416,000
Q3 2022

Nov 14, 2022

BUY
$1.04 - $1.27 $294,736 - $359,918
283,400 Added 77.3%
650,000 $650,000
Q2 2022

Aug 12, 2022

BUY
$0.94 - $1.76 $250,285 - $468,619
266,261 Added 265.36%
366,600 $451,000
Q1 2022

May 13, 2022

BUY
$1.42 - $2.09 $142,481 - $209,708
100,339 New
100,339 $150,000
Q4 2021

Feb 11, 2022

SELL
$1.42 - $2.13 $460,122 - $690,183
-324,030 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$1.42 - $2.0 $357,044 - $502,880
251,440 Added 346.38%
324,030 $541,000
Q2 2021

Aug 13, 2021

SELL
$1.21 - $1.89 $967,779 - $1.51 Million
-799,818 Reduced 91.68%
72,590 $137,000
Q1 2021

May 13, 2021

BUY
$1.31 - $3.0 $215,774 - $494,139
164,713 Added 23.27%
872,408 $1.47 Million
Q4 2020

Feb 10, 2021

BUY
$0.96 - $1.51 $3,931 - $6,183
4,095 Added 0.58%
707,695 $948,000
Q3 2020

Nov 13, 2020

BUY
$0.98 - $1.52 $50,485 - $78,304
51,516 Added 7.9%
703,600 $703,000
Q2 2020

Aug 13, 2020

BUY
$0.84 - $1.11 $378,896 - $500,684
451,067 Added 224.39%
652,084 $645,000
Q1 2020

May 14, 2020

SELL
$0.79 - $1.7 $13,309 - $28,639
-16,847 Reduced 7.73%
201,017 $171,000
Q4 2019

Feb 13, 2020

BUY
$0.72 - $0.9 $3,789 - $4,736
5,263 Added 2.48%
217,864 $179,000
Q3 2019

Nov 13, 2019

SELL
$0.74 - $0.87 $5,065 - $5,955
-6,845 Reduced 3.12%
212,601 $166,000
Q2 2019

Aug 12, 2019

BUY
$0.79 - $1.66 $32,469 - $68,226
41,100 Added 23.05%
219,446 $187,000
Q1 2019

May 14, 2019

BUY
$0.73 - $2.1 $32,704 - $94,080
44,800 Added 33.55%
178,346 $250,000
Q4 2018

Feb 13, 2019

BUY
$0.63 - $1.12 $84,133 - $149,571
133,546 New
133,546 $95,000

Others Institutions Holding DARE

About Dare Bioscience, Inc.


  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $34.8M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.